This is a demo store. No orders will be fulfilled.
放射性核素偶联药物 (RDCs)
-
二亚乙基三胺五乙酸二酐(DTPA)CAS号: 23911-26-4分子式: C14H19N3O8 分子量: 357.32IUPAC Name: 2-[bis[2-(2,6-dioxomorpholin-4-yl)ethyl]amino]acetic acidSMILES: C1C(=O)OC(=O)CN1CCN(CCN2CC(=O)OC(=O)C2)CC(=O)OInChIKey: RAZLJUXJEOEYAM-UHFFFAOYSA-NInChI: 1S/C14H19N3O8/c18-10(19)5-15(1-3-16-6-11(20)24-12(21)7-16)2-4-17-8-13(22)25-14(23)9-17/h1-9H2,(H,18,19)
-
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸三叔丁酯CAS号: 137076-54-1 Compound CID : 11606627分子式: C28H52N4O8 分子量: 572.74IUPAC Name: 2-[4,7,10-tris[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acidSMILES: CC(C)(C)OC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)CC(=O)OInChIKey: RVUXZXMKYMSWOM-UHFFFAOYSA-NInChI: 1S/C28H52N4O8/c1-26(2,3)38-23(35)19-30-12-10-29(18-22(33)34)11-13-31(20-24(36)39-27(4,5)6)15-17-32(16-14-30)21-25(37)40-28(7,8)9/h10-21H2,1-9H3,(H,33,34)
-
-
曲妥珠单抗关联靶标: ERBB2亚型: Human IgG1CAS号: 180288-69-1分子式: C6470H10012N1726O2013S42 分子量: 145531.50IUPAC Name: 2,8-diamino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-oneSMILES: C(C1C(C(C(O1)N2C3=C(C(=O)NC(=N3)N)N=C2N)O)O)OInChIKey: FNXPTCITVCRFRK-UMMCILCDSA-NInChI: 1S/C10H14N6O5/c11-9-14-6-3(7(20)15-9)13-10(12)16(6)8-5(19)4(18)2(1-17)21-8/h2,4-5,8,17-19H,1H2,(H2,12,13)(H3,11,14,15,20)/t2-,4-,5-,8-/m1/s1
-
2,2',2''-(1,4,7-三氮杂环壬烷-1,4,7-三基)三乙酸CAS号: 56491-86-2 Compound CID : 124326分子式: C12H21N3O6 分子量: 303.32IUPAC Name: 2-[4,7-bis(carboxymethyl)-1,4,7-triazonan-1-yl]acetic acidSMILES: C1CN(CCN(CCN1CC(=O)O)CC(=O)O)CC(=O)OInChIKey: JHALWMSZGCVVEM-UHFFFAOYSA-NInChI: 1S/C12H21N3O6/c16-10(17)7-13-1-2-14(8-11(18)19)5-6-15(4-3-13)9-12(20)21/h1-9H2,(H,16,17)(H,18,19)(H,20,21)
-
利妥昔单抗(抗CD20)关联靶标: MS4A1简短描述: 免疫学和炎症相关抗体种属反应性: 人(Human) 亚型: Human IgG1偶联: UnconjugatedCAS号: 174722-31-7 Compound CID : 168009840SMILES: See more
-
Trastuzumab (anti-HER2)关联靶标: ERBB2简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 小鼠(Mouse) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 180288-69-1分子式: C6470H10012N1726O2013S42 分子量: 145531.50IUPAC Name: 2,8-diamino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-oneSMILES: C(C1C(C(C(O1)N2C3=C(C(=O)NC(=N3)N)N=C2N)O)O)OInChIKey: FNXPTCITVCRFRK-UMMCILCDSA-NInChI: 1S/C10H14N6O5/c11-9-14-6-3(7(20)15-9)13-10(12)16(6)8-5(19)4(18)2(1-17)21-8/h2,4-5,8,17-19H,1H2,(H2,12,13)(H3,11,14,15,20)/t2-,4-,5-,8-/m1/s1
-
Cetuximab (anti-EGFR)关联靶标: EGFR简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level< 0.01EU/μg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 205923-56-4分子式: 分子量: 145543.35
-
2,2',2''-(1,4,7-三氮杂环壬烷-1,4,7-三基)三乙酸CAS号: 56491-86-2 Compound CID : 124326分子式: C12H21N3O6 分子量: 303.32IUPAC Name: 2-[4,7-bis(carboxymethyl)-1,4,7-triazonan-1-yl]acetic acidSMILES: C1CN(CCN(CCN1CC(=O)O)CC(=O)O)CC(=O)OInChIKey: JHALWMSZGCVVEM-UHFFFAOYSA-NInChI: 1S/C12H21N3O6/c16-10(17)7-13-1-2-14(8-11(18)19)5-6-15(4-3-13)9-12(20)21/h1-9H2,(H,16,17)(H,18,19)(H,20,21)
-
PAMAM 树枝状聚合物,乙二胺核,3.0 溶液CAS号: 153891-46-4分子式: [NH2(CH2)2NH2]:(G=3);dendri PAMAM(NH2)32 分子量: 6908.84
-
Lintuzumab (anti-CD33)关联靶标: CD33简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level < 0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 166089-32-3
-
2-Aminoethyl-mono-amide-DOTA-tris(tBu ester)CAS号: 173308-19-5 Compound CID : 22660448分子式: C30H58N6O7 分子量: 614.82IUPAC Name: tert-butyl 2-[4-[2-(2-aminoethylamino)-2-oxoethyl]-7,10-bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetateSMILES: CC(C)(C)OC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)CC(=O)NCCNInChIKey: TVUPYCMMXREXSS-UHFFFAOYSA-NInChI: 1S/C30H58N6O7/c1-28(2,3)41-25(38)21-34-14-12-33(20-24(37)32-11-10-31)13-15-35(22-26(39)42-29(4,5)6)17-19-36(18-16-34)23-27(40)43-30(7,8)9/h10-23,31H2,1-9H3,(H,32,37)
首页
400-620-6333







